Intra-gene DNA methylation variability is a clinically independent prognostic marker in women’s cancers
Ontology highlight
ABSTRACT: Differences in DNA methylation (DNAm) levels are amongst the earliest changes in human carcinogenesis, and are a hallmark of cancer, offering the potential for novel strategies to predict cancer biology and outcome. Hence, DNAm markings might provide a valuable lead for the development of DNA-based cancer biomarkers in tissue and bodily fluids. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles across approximately 480,000 CpGs in a total of 221 samples, including 171 serous, 18 endometrioid, 14 clear cell, 9 mucinous and 9 other histological cancer subtypes.
ORGANISM(S): Homo sapiens
PROVIDER: GSE72021 | GEO | 2015/08/13
SECONDARY ACCESSION(S): PRJNA292752
REPOSITORIES: GEO
ACCESS DATA